Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Are exacerbations the most relevant outcome parameters in COPD clinical trials?

COPD is a life threatening disease which negatively affects normal breathing. It is characterised by persistent blockage of air flow to the lungs. COPD encapsulates chronic bronchitis and emphysema. The most common cause of patients getting COPD is tobacco smoke. This is either from smoking or from second hand smoke


COPDCOPD is not curable and it is under-diagnosed meaning sufferer numbers may be much larger than are recorded currently. COPD cannot be cured, but effective treatment can slow its progress and reduce the numbers of deaths. One of the major focuses of research is attempts to improve patients’ quality of life.

Join SMi at their 4th annual COPD: Novel Therapeutics & Management Strategies held in London on the 22nd & 23rd October addressing the hot topics in COPD, and will emphasize developments in new therapies and issues surrounding the management of COPD and management of exacerbations of COPD.

Reasons to attend include:

  • Consider developments in the modelling and management of exacerbations of COPD
  • Evaluate unique complexities of COPD pathophysiology
  • Develop combination and oxygen therapies within COPD - learn about triple therapies and novel therapies within the treatment of COPD
  • Hear from leading industry professionals on the current clinical trials process and rapid proof of concept studies
  • Analyse all phases of the discovery process, from pre-clinical modelling, phase 2 studies all the way through to modelling clinical outcomes
  • Network with and learn from key industry professional and research leading academics
  • Discuss the latest in health economics for COPD drugs

For more information click here or contact Farhaana Rahma on tel. +44 0207 827 6186


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners